)
Chemed (CHE) investor relations material
Chemed Q3 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Q3 revenue rose 10.6% to $690.9M; GAAP diluted EPS was $5.45, up 22.2%, and adjusted diluted EPS was $6.75, up 28.1%.
VITAS growth and margin expansion offset lower adjusted EBITDA and margin at Roto-Rooter.
Financial highlights
Q3 net income was $71.6M versus $64.2M; operating income rose to $96.4M from $74.8M.
Nine-month revenue increased 6.9% to $2.02B; net income was $205.7M and diluted EPS was $15.43.
Adjusted Q3 net income was $88.7M and adjusted diluted EPS was $6.75, versus $75.9M and $5.27 a year earlier.
Nine-month operating cash flow was $229.6M versus $254.7M; investing cash outflow was $147.4M, including $96.1M for business combinations and $51.4M in capital expenditures.
Q3 dividends were $0.70 per share versus $0.60; nine-month dividends were $1.90 per share versus $1.60.
Outlook and guidance
FY2026 adjusted EPS is expected at or slightly above the high end of guidance issued after Q2.
Q4 is expected to meet prior guidance; VITAS anticipates no Florida combined-program Medicare Cap billing limitation for FY2026.
Preliminary assessment indicates tariffs and other current factors are not expected to materially harm FY2026 net sales or profitability; FY2027 planning considers pricing and cost savings to offset cost increases.
VITAS expects balanced hospital and non-hospital admission growth through the rest of 2026 and 2027; recruiting costs are not expected to rise materially in 2027.
Roto-Rooter expects historic margin discipline to return as revenue grows in 2027 and beyond; no specific 2027 budget or growth target was given.
- VITAS outperforms with margin gains and Florida growth as Roto-Rooter stabilizes amid higher costs.CHE
2026 Jefferies Healthcare Services and Technology Conference - Q2 2026 revenue and earnings surged, led by VITAS growth and major share repurchases.CHE
Q2 2026 - VITAS drives robust growth and margin expansion, positioning for industry-leading hospice consolidation.CHE
43rd Annual J.P. Morgan Healthcare Conference 2025 - Admissions growth and CAP mitigation are ahead of plan, with strong execution in new markets.CHE
RBC Capital Markets Global Healthcare Conference 2026 - Raised hospice growth outlook, selective expansion, and digital strategies support margin gains.CHE
Bank of America Global Healthcare Conference 2026 - VITAS outperformed, boosting guidance, while Roto-Rooter faced margin pressure and revenue decline.CHE
Q1 2026 - Proxy details director elections, auditor ratification, pay-for-performance, and strong governance.CHE
Proxy filing - Hospice growth remains robust with stable margins, while Roto-Rooter shows signs of recovery.CHE
Bank of America Home Care Conference - VITAS drives strong growth while Roto-Rooter adapts to competition and digital marketing shifts.CHE
UBS Global Healthcare Conference 2024
Next Chemed earnings date
Next Chemed earnings date
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
)
)